{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:57:14Z","timestamp":1791817034721,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-cot.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Orthopaedics and Trauma"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jcot.2019.09.017","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T11:51:24Z","timestamp":1570794684000},"page":"1015-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Present day controversies and consensus in curettage for giant cell tumor of bone"],"prefix":"10.1016","volume":"10","author":[{"given":"Costantino","family":"Errani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Maria","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcot.2019.09.017_bib1","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1007\/s11999-011-1962-3","article-title":"Similar local control between phenol- and ethanol-treated giant cell tumors of bone","volume":"469","author":"Lin","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.jcot.2019.09.017_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2106\/JBJS.J.01922","article-title":"Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution","volume":"94","author":"Niu","year":"2012","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.jcot.2019.09.017_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11999-010-1560-9","article-title":"Recurrent giant cell tumor of long bones: analysis of surgical management","volume":"469","author":"Klenke","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.jcot.2019.09.017_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s11999-008-0583-y","article-title":"Conservative treatment of Campanacci grade III proximal humerus giant cell tumors","volume":"467","author":"Lackman","year":"2009","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.jcot.2019.09.017_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","article-title":"The clinical approach toward giant cell tumor of bone","volume":"19","author":"van der Heijden","year":"2014","journal-title":"The Oncologist"},{"key":"10.1016\/j.jcot.2019.09.017_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.blo.0000128280.59965.e3","article-title":"Results of giant cell tumor of bone treated with intralesional excision","volume":"424","author":"Saiz","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jcot.2019.09.017_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.blo.0000160024.06739.ff","article-title":"Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?","volume":"435","author":"Prosser","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"10.1016\/j.jcot.2019.09.017_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12306-016-0413-4","article-title":"Structural allograft reconstruction of the foot and ankle after tumor resections","volume":"100","author":"Ayerza","year":"2016","journal-title":"Musculoskelet Surg"},{"issue":"1","key":"10.1016\/j.jcot.2019.09.017_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/17453670710014815","article-title":"Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years","volume":"79","author":"Kivioja","year":"2008","journal-title":"Acta Orthop"},{"key":"10.1016\/j.jcot.2019.09.017_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00003086-200204000-00029","article-title":"Giant cell tumor of long bone: a Canadian Sarcoma Group study","volume":"397","author":"Turcotte","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jcot.2019.09.017_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1477-7819-11-156","article-title":"Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis","volume":"11","author":"Zuo","year":"2013","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jcot.2019.09.017_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00003086-200207000-00025","article-title":"Giant-cell tumor of the appendicular skeleton","volume":"400","author":"Ghert","year":"2002","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.jcot.2019.09.017_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00264-004-0564-z","article-title":"Giant-cell tumors of bone: an analysis of 87 cases","volume":"28","author":"Su","year":"2004","journal-title":"Int Orthop"},{"issue":"6","key":"10.1016\/j.jcot.2019.09.017_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00590-017-1983-z","article-title":"Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites","volume":"27","author":"Errani","year":"2017","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"7","key":"10.1016\/j.jcot.2019.09.017_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jso.25391","article-title":"Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation","volume":"119","author":"Tsukamoto","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jcot.2019.09.017_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/BLO.0b013e31805d85e4","article-title":"Joint salvage for pathologic fracture of giant cell tumor of the lower extremity","volume":"459","author":"Deheshi","year":"2007","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.jcot.2019.09.017_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/17453674.2012.711193","article-title":"Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones","volume":"83","author":"van der Heijden","year":"2012","journal-title":"Acta Orthop"},{"issue":"6","key":"10.1016\/j.jcot.2019.09.017_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2106\/JBJS.17.00057","article-title":"Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage","volume":"100","author":"Errani","year":"2018","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jcot.2019.09.017_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.01.006","article-title":"Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone","volume":"59","author":"Traub","year":"2016","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.jcot.2019.09.017_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcot.2019.09.017_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/ejso.2000.1086","article-title":"Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy","volume":"27","author":"Trieb","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jcot.2019.09.017_bib22","first-page":"69","article-title":"Ethanol as a local adjuvant for giant cell tumor of bone","volume":"26","author":"Jones","year":"2006","journal-title":"Iowa Orthop J"},{"issue":"6","key":"10.1016\/j.jcot.2019.09.017_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00264-006-0154-3","article-title":"Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant","volume":"30","author":"Oh","year":"2006","journal-title":"Int Orthop"},{"issue":"5","key":"10.1016\/j.jcot.2019.09.017_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2106\/JBJS.D.02771","article-title":"Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy","volume":"90","author":"Knochentumoren","year":"2008","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"12","key":"10.1016\/j.jcot.2019.09.017_bib25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1302\/0301-620X.93B12.27663","article-title":"Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?","volume":"93","author":"Gaston","year":"2011","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"1","key":"10.1016\/j.jcot.2019.09.017_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00432-008-0427-x","article-title":"Treatment options for recurrent giant cell tumors of bone","volume":"135","author":"Balke","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jcot.2019.09.017_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.blo.0000180055.76969.08","article-title":"Impact severity of local recurrence in giant cell tumor of bone","volume":"438","author":"McGough","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"10.1016\/j.jcot.2019.09.017_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11420-009-9125-8","article-title":"Cryosurgery and impaction subchondral bone graft for the treatment of giant cell tumor around the knee","volume":"5","author":"Abdelrahman","year":"2009","journal-title":"HSS J"},{"issue":"7","key":"10.1016\/j.jcot.2019.09.017_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3928\/01477447-20090527-08","article-title":"Treatment of giant cell tumor of long bones: clinical outcome and reconstructive strategy for lower and upper limbs","volume":"32","author":"Muramatsu","year":"2009","journal-title":"Orthopedics"},{"issue":"2","key":"10.1016\/j.jcot.2019.09.017_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1302\/0301-620X.86B2.14362","article-title":"Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft","volume":"86","author":"Zhen","year":"2004","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.jcot.2019.09.017_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.blo.0000180051.27961.c3","article-title":"Intralesional curettage for grades II and III giant cell tumors of bone","volume":"438","author":"Lackman","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.jcot.2019.09.017_bib32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s11999-016-4755-x","article-title":"Supplemental bone grafting in giant cell tumor of the extremity reduces nononcologic complications","volume":"475","author":"Benevenia","year":"2017","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.jcot.2019.09.017_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","article-title":"Giant cell tumor of the extremity: a review of 349 cases from a single institution","volume":"36","author":"Errani","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.jcot.2019.09.017_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1302\/0301-620X.89B3.18604","article-title":"Giant-cell tumour of the knee: the condition of the cartilage after treatment by curettage and cementing","volume":"89","author":"von Steyern","year":"2007","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"1","key":"10.1016\/j.jcot.2019.09.017_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1302\/0301-620X.96B1.31763","article-title":"Giant cell tumour of the proximal femur: is joint-sparing management ever successful?","volume":"96-B","author":"Wijsbek","year":"2014","journal-title":"Bone Joint Lett J"},{"key":"10.1016\/j.jcot.2019.09.017_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/586090","article-title":"High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis","author":"Algawahmed","year":"2010","journal-title":"Sarcoma"},{"issue":"11","key":"10.1016\/j.jcot.2019.09.017_bib37","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1302\/0301-620X.97B11.35326","article-title":"Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone?: a meta-analysis","volume":"97-B","author":"Salunke","year":"2015","journal-title":"Bone Joint Lett J"},{"issue":"11","key":"10.1016\/j.jcot.2019.09.017_bib38","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00264-017-3536-9","article-title":"How safe and effective is denosumab for bone giant cell tumour?","volume":"41","author":"Errani","year":"2017","journal-title":"Int Orthop"}],"container-title":["Journal of Clinical Orthopaedics and Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0976566219304965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0976566219304965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:18:03Z","timestamp":1760854683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0976566219304965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0976566219304965"],"URL":"https:\/\/doi.org\/10.1016\/j.jcot.2019.09.017","relation":{},"ISSN":["0976-5662"],"issn-type":[{"value":"0976-5662","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Present day controversies and consensus in curettage for giant cell tumor of bone","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Orthopaedics and Trauma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcot.2019.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Delhi Orthopedic Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}